1 minute read

IGNITE EVENTS

Octane events are designed to create connections within the Southern California business and entrepreneurial community. In 2022, Octane set new attendance records including an introduction of a new event, our inaugural Cardiovascular Tech Summit. Over 7,500 people attended our various forums, summits, webinars, and other events.

Our premier events bring together industry leaders, entrepreneurs, investors, physicians & startups that will shape the future. As we look ahead to 2023, the Octane Events team has secured key thought leaders as keynote speakers for all its Signature Events. All our content is now able to be consumed on-demand, at the attendee’s convenience, establishing Octane as a leading content provider.

Advertisement

Overall Rating

Aesthetics Tech Forum

Guided by the strength of innovation happening locally, Octane kicked off the year with our Aesthetics Tech Forum in January. Over 550 attendees which included 200 physicians, as well as industry, investors, and entrepreneurs, gathered to discuss the future of medical aesthetics.

The two-day event hosted over 60 speakers in 20 sessions, representing leaders from clinical, pharmaceutical, and medical device companies. Highlights of the event included a keynote by Carrie Strom, SVP, AbbVie, President, Global Allergan Aesthetics interviewed by Bill Carpou, CEO, Octane and several panels discussing topics such as investment opportunities, regulatory pathways, and more.

One of the most discussed panels was the science of aging panel, which included speakers Dr. Stephanie Manson Brown, MBBS, MRCS, MFPM, Vice President, Head of Clinical Development, Aesthetic Medicine, Allergan Aesthetics an AbbVie Company, David McDaniel, MD, Co-Director of the Hampton University Skin of Color Research Institute, Patricia Ogilvie, MD, Founder of SkinConcept Munich, and Sophia Ononye-Onyia, PhD, MPH, MBA, Founder & CEO, The Sophia Consulting Firm.

Aesthetics Tech Forum also featured presentations from LaunchPad SBDC medical aesthetics tech startups. The presenting companies were Accure Acne, Inc., Acorn Biolabs, Elevai Labs Inc, and LoveMyDelta, Inc. Each presented a 10-minute pitch and had a panel of experienced investor judges and physicians for a round of questions.

This article is from: